{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:36:55Z","timestamp":1764175015346,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.taap.2021.115578","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T10:59:41Z","timestamp":1621076381000},"page":"115578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12C, are associated with renal toxicity in the Sprague Dawley rat"],"prefix":"10.1016","volume":"423","author":[{"given":"Jonathan A.","family":"Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhian","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Wahlstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upendra P.","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Stauber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Siska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Griffith","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Russell","family":"Lipford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Monticello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115578_bb0005","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium","volume":"7","author":"AACR","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.taap.2021.115578_bb0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev.pharmtox.45.120403.095847","article-title":"Formation and toxicity of anesthetic degradation products","volume":"45","author":"Anders","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2021.115578_bb0015","first-page":"1","article-title":"Approaches to mitigate the risk of serious adverse reactions in covalent drug design","author":"Baillie","year":"2020","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.taap.2021.115578_bb0020","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1146\/annurev.bi.56.070187.004023","article-title":"ras genes","volume":"56","author":"Barbacid","year":"1987","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.taap.2021.115578_bb0025","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/toxsci\/kfy159","article-title":"Nephrotoxicity and renal pathophysiology: a contemporary perspective","volume":"164","author":"Barnett","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2021.115578_bb0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.taap.2021.115578_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202706","article-title":"Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate)","volume":"13","author":"Ceckova","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2021.115578_bb0040","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.79.16.4848","article-title":"Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses","volume":"79","author":"Chang","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2021.115578_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/B978-0-12-801238-3.01973-5","article-title":"Metabolism of glutathione S-conjugates: multiple pathways","author":"Cooper","year":"2018","journal-title":"Comprehensive Toxicol."},{"key":"10.1016\/j.taap.2021.115578_bb0050","first-page":"1833","article-title":"Species-specific nephrotoxicity induced by glutathione conjugation of efavirenz in rats","volume":"48","author":"Gerson","year":"1999"},{"key":"10.1016\/j.taap.2021.115578_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0041-008X(90)90264-U","article-title":"Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans","volume":"103","author":"Green","year":"1990","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2021.115578_bb0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-4274(02)00372-7","article-title":"Assessing the health risks following environmental exposure to hexachlorobutadiene","volume":"138","author":"Green","year":"2003","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2021.115578_bb0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/dmd.30.2.148","volume":"30","author":"Gul Altuntas","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2021.115578_bb0070","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/clpt.1981.56","article-title":"Determination of mean valproic acid serum level by assay of a single pooled sample","volume":"29","author":"Hamilton","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115578_bb0075","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/10408444.2019.1692191","article-title":"The mercapturic acid pathway","volume":"49","author":"Hanna","year":"2019","journal-title":"Crit. Rev. Toxicol."},{"issue":"13","key":"10.1016\/j.taap.2021.115578_bb0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","article-title":"KRASG12C inhibition with sotorasib in advanced solid tumors","volume":"383","author":"Hong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2021.115578_bb0085","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0041-008X(92)90238-N","article-title":"Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat","volume":"117","author":"Horvath","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2021.115578_bb0090","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/00000542-199612000-00028","article-title":"Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine S-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria","volume":"85","author":"Iyer","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.taap.2021.115578_bb0095","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm2438","article-title":"Ras oncogenes: split personalities","volume":"9","author":"Karnoub","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2021.115578_bb0100","first-page":"311","article-title":"Morphologic responses to a murine erythroblastosis virus","volume":"39","author":"Kirsten","year":"1967","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.taap.2021.115578_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/acs.jmedchem.9b01180","article-title":"Discovery of a covalent inhibitor of KRAS(G12C) (AMG 510) for the treatment of solid tumors","volume":"63","author":"Lanman","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2021.115578_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0090-9556(25)07586-5","article-title":"Purification and characterization of human kidney cytosolic cysteine conjugate beta-lyase activity","volume":"18","author":"Lash","year":"1990","journal-title":"Drug Metab. Dispos."},{"year":"2021","series-title":"PS02.07 - CodeBreak 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutant NSCLC, 2020 World Conference on Lung Cancer, Singapore","author":"Li","key":"10.1016\/j.taap.2021.115578_bb0115"},{"key":"10.1016\/j.taap.2021.115578_bb0120","series-title":"Comprehensive Toxicology","first-page":"30","article-title":"14.03 - renal xenobiotic metabolism","author":"Lock","year":"2018"},{"key":"10.1016\/j.taap.2021.115578_bb0125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623310373778","article-title":"Hepatic enzyme induction: histopathology","volume":"38","author":"Maronpot","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.taap.2021.115578_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/074823379401000107","article-title":"Cytosolic C-S lyase activity in human kidney samples-relevance for the nephrotoxicity of halogenated alkenes in man","volume":"10","author":"McCarthy","year":"1994","journal-title":"Toxicol. Ind. Health"},{"key":"10.1016\/j.taap.2021.115578_bb0135","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/toxins2112490","article-title":"Mechanisms of Cisplatin nephrotoxicity","volume":"2","author":"Miller","year":"2010","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.taap.2021.115578_bb0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/taap.2000.9055","article-title":"The species-dependent metabolism of efavirenz produces a nephrotoxic glutathione conjugate in rats","volume":"169","author":"Mutlib","year":"2000","journal-title":"Toxicol. Appl. Pharmacol."},{"year":"2011","series-title":"Guide for the Care and Use of Laboratory Animals","author":"NRC","key":"10.1016\/j.taap.2021.115578_bb0145"},{"year":"2015","series-title":"Public Health Services Policy on Humane Care and Use of Laboratory Animals","author":"OLAW","key":"10.1016\/j.taap.2021.115578_bb0150"},{"key":"10.1016\/j.taap.2021.115578_bb0155","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2215\/CJN.00150118","article-title":"Pharmacology behind common drug Nephrotoxicities","volume":"13","author":"Perazella","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"33","key":"10.1016\/j.taap.2021.115578_bb0160","first-page":"14","article-title":"KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target","volume":"17","author":"Rom\u00e1n","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.taap.2021.115578_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10637-020-00970-x","article-title":"Extrahepatic metabolism of ibrutinib","volume":"39","author":"Rood","year":"2020","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.taap.2021.115578_bb0170","series-title":"The Practice of Medicinal Chemistry","first-page":"561","article-title":"Chapter 24 - biotransformation reactions and their enzymes","author":"Testa","year":"2015"},{"key":"10.1016\/j.taap.2021.115578_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/toxsci\/kfz093","article-title":"Relationship of MATE1 inhibition and cytotoxicity in nephrotoxicity: application for safety evaluation in early drug discovery","volume":"170","author":"Tohyama","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2021.115578_bb0180","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/jpet.300.1.142","article-title":"Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice","volume":"300","author":"Townsend","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2021.115578_bb0185","series-title":"Encyclopedia of Cancer","first-page":"297","article-title":"Glutathione transferases","author":"Tsuchida","year":"2002"},{"key":"10.1016\/j.taap.2021.115578_bb0190","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/jpet.103.052225","article-title":"Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin","volume":"306","author":"Zhang","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2100185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2100185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:55:42Z","timestamp":1758574542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2100185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"alternative-id":["S0041008X2100185X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115578","relation":{},"ISSN":["0041-008X"],"issn-type":[{"type":"print","value":"0041-008X"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRASG12C, are associated with renal toxicity in the Sprague Dawley rat","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115578"}}